APX Technologies Inc Competitors

Atlas Technology Group is a technology-focused investment bank with particular expertise in providing sell-side M&A advisory services to global software companies. Our other services cover the full range of strategic transactions including buy-side M&A advisory, private placements, carve outs, and spin offs. We offer our combination of sector-based expertise and investment banking skills to companies globally from our offices in San Francisco. The quality of our differentiated advice is a function of both our focus and the depth of experience of our partners, who were senior technology bankers (both bulge bracket and boutique), research analysts, and public and private equity investors with extensive track records prior to coming together at Atlas. Our partners are “hands-on” in managing assignments and typically operate as multi-partner teams. We bring our clients, whether public or private companies, unparalleled access to strategic buyers and PE/growth investors globally. Ultimately, our strengths in providing strategic and tactical expertise, critical industry knowledge, relationships with strategic buyers, and our partners’ depth of deal experience and business judgment make Atlas the “advisor of choice” in technology M&A. Atlas Technology Group is a member of FINRA. BrokerCheck firm summary available at http://brokercheck.finra.org/Firm/Summary/152828.

We are working for you where you getting struck in Excel. We can able to do Extract the data from PDF files into Excel. Understanding Customer requirements. Able produce 100% Accuracy within Timeline. You can catch me @ karampuri.sathish62@gmail.com /9110336070

Crescent Innovations, Inc. is an early stage medical product company located in Massachusetts. The company focuses on research and development of biologically compatible polymers in order to provide nonsurgical REGENERATIVE therapies for treating chronic and acute episodes of pain. Crescent Innovations has an advanced candidate to treat osteoarthritis, which has the potential to be more effective, less expensive than traditional, therapies, and require less treatment to achieve pain reduction.